Abstract Background and Aims One of the most common hemoglobinopathies globally related to blood transfusion and iron overload in the body is thalassemia syndrome. Increasing ferritin levels can cause severe damage to the patient's body organs. This study aims to evaluate the complications of iron overload on vital body organs in patients with transfusion‐dependent beta‐thalassemia. Methods This descriptive cross‐sectional study was performed in Iran University of Medical Sciences Hospitals on patients with a beta‐thalassemia major with frequent blood transfusions. To evaluate the effect of iron overload on vital body organs, hematologic and blood analysis, echocardiography with measurement of pulmonary artery pressure (PAP) and ejection fr...
Iron overload due to increased intestinal iron absorption represents an important clinical problem i...
Objective: To evaluate causes of hospitalization (due to complications of iron overload and other ca...
Background The commonest form of life-long treatment for individuals with β-thalassaemia major (TM) ...
Thalassemia is a genetic disease caused by disruption of globin chain synthesis leading to severe an...
Introduction: Thalassemia is a genetic condition and is one of the commonest single-gene hereditary ...
Heart disease remains a leading cause of morbidity and mortality in transfusion-dependent thalassemi...
Background Patients with \u3b2 thalassemia intermedia can have substantial iron overload, irrespecti...
Introduction: Cardiac complications are the leading cause of mortality amongst transfusion-dependent...
Beta-thalassemia major is a genetic disorder adversely affecting the life of the patient and the who...
This cross-sectional study aimed to establish the association between serum ferritin levels and orga...
BackgmundThalassemia is the most cormnon hereditary haemolytic anaemia in the world, including in In...
Background: Cardiac iron toxicity is a major cause of mortality in transfusion-dependent beta-thalas...
Abstract Background The combination of transfusion and chelation therapy has dramatically extended t...
To study the effect of iron overload due to continuous blood transfusions on peroxidation products, ...
Thalassemic disorders lie on a phenotypic spectrum of clinical severity that depends on the severity...
Iron overload due to increased intestinal iron absorption represents an important clinical problem i...
Objective: To evaluate causes of hospitalization (due to complications of iron overload and other ca...
Background The commonest form of life-long treatment for individuals with β-thalassaemia major (TM) ...
Thalassemia is a genetic disease caused by disruption of globin chain synthesis leading to severe an...
Introduction: Thalassemia is a genetic condition and is one of the commonest single-gene hereditary ...
Heart disease remains a leading cause of morbidity and mortality in transfusion-dependent thalassemi...
Background Patients with \u3b2 thalassemia intermedia can have substantial iron overload, irrespecti...
Introduction: Cardiac complications are the leading cause of mortality amongst transfusion-dependent...
Beta-thalassemia major is a genetic disorder adversely affecting the life of the patient and the who...
This cross-sectional study aimed to establish the association between serum ferritin levels and orga...
BackgmundThalassemia is the most cormnon hereditary haemolytic anaemia in the world, including in In...
Background: Cardiac iron toxicity is a major cause of mortality in transfusion-dependent beta-thalas...
Abstract Background The combination of transfusion and chelation therapy has dramatically extended t...
To study the effect of iron overload due to continuous blood transfusions on peroxidation products, ...
Thalassemic disorders lie on a phenotypic spectrum of clinical severity that depends on the severity...
Iron overload due to increased intestinal iron absorption represents an important clinical problem i...
Objective: To evaluate causes of hospitalization (due to complications of iron overload and other ca...
Background The commonest form of life-long treatment for individuals with β-thalassaemia major (TM) ...